During the past decade, Kagawa University School of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kagawa University School of Medicine" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "The National Institute of Biomedical Innovation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kagawa University School of Medicine" are "Alzheimer Dementia" (1 trials), "Cerebral Infarction" (1 trials), "Coronary Disease" (1 trials) and "Ischemic Attack, Transient" (1 trials). Many other conditions were trialed in "Kagawa University School of Medicine" in a lesser frequency.

Most popular intervention types in "Kagawa University School of Medicine" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Observation" (1 trials) and "Standard therapy of Alzheimer Dementia (AD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kagawa University School of Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kagawa University School of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kagawa University School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kagawa University School of Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".